Skip to main content

Table 2 NIV modalities against IMV for mortality Meta-regressions models

From: Noninvasive oxygenation and ventilation strategies for viral acute respiratory failure: a comprehensive systematic review and meta-analysis

NIV modalities and model

n studies

I2

R2

Covariant

Estimate

NIMV with imputed data and abstract congress

17

92.98

0

Intercept

 − 0.52

Influenza

0.11

Age

0.006

PaO2/FiO2

 − 0.001

NIMV without imputed data and no abstract congress

8

85.56

0

Intercept

11.76

Influenza

 − 3.21

Age

0.006

PaO2/FiO2

 − 0.17

NIMV with imputed data and no abstract congress

15

93.19

17.47

Intercept

 − 0.52

Influenza

0.11

Age

0.006

PaO2/FiO2

 − 0.001

HFNC with imputed data and abstract congress

11

69.61

14.3

intercept

 − 2.097

Age

0.01

SOFA

0.19

HFNC without imputed data and no abstract congress

5

9.01

69.45

intercept

 − 15.04

APACHEII

1.18

SOFA

0.77

HFNC with imputed data and no abstract congress

9

36.23

50.02

intercept

 − 2.94

Age

0.02

SOFA

0.19

CPAP with imputed data and abstract congress

8

0

100

Intercept

0.41

Age

 − 0.01

PaO2/FiO2

 − 0.01

CPAP without imputed data and abstract congress

6

42.43

0

Intercept

0.81

Age

 − 0.02

CPAP with imputed data and no abstract congress

5

57.90

0

Intercept

0.96

Age

 − 0.02